Lori La Bey welcomes back Sharon L. Rogers, the CEO of AmyriAD Therapeutics. Sharon was previously chief of research at Eisai, where she played a leading role in developing Aricept, the top-selling Alzheimer's medication on the market. Learn: Who is really funding early-stage trials? What is the difference between Pharma and Social Therapies? Do we know how many forms of dementia there are? What does having a complex dementia mean? Does a change in diagnosis affect a clinical trial? About the Domino’s Study. Will there be a silver bullet medication for dementia in the near future?   Listen and Subscribe to Alzheimer’s Speaks on Apple Podcast https://podcasts.apple.com/us/podcast/alzheimers-speaks/id986940432   Listen and Subscribe to Alzheimer’s Speaks on Spotify https://open.spotify.com/show/255okRnEgfCUqXq1NWcrT3    Contact AmyriAD Therapeutics Website      https://amyriadtherapeutics.com/ LinkedIn      https://www.linkedin.com/company/amyriad-therapeutics/ Twitter        https://twitter.com/AmyriAD_Tx   Contact Lori La Bey with questions or branding needs at https://www.alzheimersspeaks.com/ Alzheimer's Speaks Radio - Shifting dementia care from crisis to comfort around the world one episode at a time by raising all voices and delivering sound news, not just sound bites since 2011. Alzheimer's Speaks is part of the Senior Resource Podcast Network  Support this Show: https://alzheimersspeaks.com/donate-now/See omnystudio.com/listener for privacy information.

Ver todos los episodios